ENWEI PHARMACEUTICAL: Wholly-owned subsidiary obtained the renewed "Drug Manufacturing License"

Zhitong
2025.03.25 08:58

ENWEI PHARMACEUTICAL announced that its wholly-owned subsidiaries, Henan Xinxin Pharmaceutical Co., Ltd., Sichuan ENWEI Pharmaceutical Co., Ltd., and ENWEI Pharmaceutical Co., Ltd. have recently obtained the "Drug Production License" reissued by the drug regulatory authority. Among them, the production address of Henan Xinxin Pharmaceutical Co., Ltd. is No. 56 Longhai Middle Road, Zhengzhou City, and No. 458 Section 3, Shuanghua Road, Shuangliu District, Chengdu City, Sichuan Province, with a production scope including tablets, granules, etc.; the production address of Sichuan ENWEI Pharmaceutical Co., Ltd. is No. 458 Section 3, Shuanghua Road, Shuangliu District, Chengdu City, Sichuan Province, with a production scope including tablets, granules, etc.; the production address of ENWEI Pharmaceutical Co., Ltd. is South District, Industrial Park, Yongfeng County, Ji'an City, Jiangxi Province, with a production scope including decoctions, oral solutions, etc. In addition, Henan Xinxin Pharmaceutical Co., Ltd. has also entrusted ENWEI Pharmaceutical Co., Ltd. to produce varieties such as Ginseng Yangrong Paste, Yangyin Qingfei Paste, and Apricot-Su Cough Syrup

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer